Dr. Christopher Fuller, M.D.
What this data tells you about Dr. Fuller
Dr. Christopher Fuller is an ophthalmology specialist in Lubbock, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fuller performed 63,918 Medicare services across 4,415 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fuller received a total of $61,731 from 37 pharmaceutical and/or device companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fuller is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
51,790 | $28 | $81 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
3,014 | $29 | $100 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
2,432 | $120 | $331 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
1,686 | $87 | $1,045 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,035 | $82 | $200 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
945 | $60 | $200 |
| Aflibercept eye injection (Eylea) | 665 | $677 | $2,199 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
443 | $105 | $275 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
337 | $144 | $401 |
| Fluocinolone acetonide intravitreal implant (Yutiq) A small implant placed inside the eye to release fluocinolone acetonide, a corticosteroid, over time. |
270 | $411 | $1,111 |
| Injection, brolucizumab-dbll, 1 mg | 258 | $242 | $733 |
| Fluocinolone acetonide intravitreal implant An implant containing fluocinolone acetonide is placed inside the eye to deliver medication directly to the vitreous. |
247 | $355 | $899 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
235 | $1,765 | $5,643 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
156 | $224 | $513 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
76 | $93 | $285 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
53 | $1,101 | $2,650 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
51 | $71 | $162 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
50 | $662 | $4,000 |
| Laser destruction of vitreous and retina A laser procedure used to destroy fluid in the vitreous and tissue across the entire retina. |
30 | $784 | $5,000 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
26 | $37 | $305 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
25 | $880 | $5,700 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
24 | $865 | $6,000 |
| Removal of retinal membrane A surgical procedure to remove a membrane from the surface of the retina. |
21 | $869 | $5,500 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
20 | $47 | $143 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
17 | $18 | $105 |
| Fluorescein angiography of retina A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected. |
12 | $174 | $615 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (48%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for ophthalmology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Fuller is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with speaking/promotional industry engagement in the top 5% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Fuller experienced with eye injection (vabysmo/faricimab)?
Does Dr. Fuller receive payments from pharmaceutical companies?
How do Dr. Fuller's costs compare to other ophthalmologists in Lubbock?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology